These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 28085283)
1. Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB Iyer MR; Cinar R; Katz A; Gao M; Erdelyi K; Jourdan T; Coffey NJ; Pacher P; Kunos G J Med Chem; 2017 Feb; 60(3):1126-1141. PubMed ID: 28085283 [TBL] [Abstract][Full Text] [Related]
2. Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia. Santos-Molina L; Herrerias A; Zawatsky CN; Gunduz-Cinar O; Cinar R; Iyer MR; Wood CM; Lin Y; Gao B; Kunos G; Godlewski G Molecules; 2021 Aug; 26(16):. PubMed ID: 34443679 [TBL] [Abstract][Full Text] [Related]
3. Peripheral Hybrid CB Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521 [TBL] [Abstract][Full Text] [Related]
4. Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis. Cinar R; Iyer MR; Liu Z; Cao Z; Jourdan T; Erdelyi K; Godlewski G; Szanda G; Liu J; Park JK; Mukhopadhyay B; Rosenberg AZ; Liow JS; Lorenz RG; Pacher P; Innis RB; Kunos G JCI Insight; 2016 Jul; 1(11):. PubMed ID: 27525312 [TBL] [Abstract][Full Text] [Related]
5. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents. Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CB Iyer MR; Cinar R; Wood CM; Zawatsky CN; Coffey NJ; Kim KA; Liu Z; Katz A; Abdalla J; Hassan SA; Lee YS J Med Chem; 2022 Feb; 65(3):2374-2387. PubMed ID: 35084860 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse. Vasiljevik T; Franks LN; Ford BM; Douglas JT; Prather PL; Fantegrossi WE; Prisinzano TE J Med Chem; 2013 Jun; 56(11):4537-50. PubMed ID: 23631463 [TBL] [Abstract][Full Text] [Related]
8. CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. Eldeeb K; Leone-Kabler S; Howlett AC J Basic Clin Physiol Pharmacol; 2016 May; 27(3):311-22. PubMed ID: 27089415 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms. Roger C; Buch C; Muller T; Leemput J; Demizieux L; Passilly-Degrace P; Cinar R; Iyer MR; Kunos G; Vergès B; Degrace P; Jourdan T Diabetes; 2020 Oct; 69(10):2120-2132. PubMed ID: 32680936 [TBL] [Abstract][Full Text] [Related]
10. Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity. Yan L; Huo P; Debenham JS; Madsen-Duggan CB; Lao J; Chen RZ; Xiao JC; Shen CP; Stribling DS; Shearman LP; Strack AM; Tsou N; Ball RG; Wang J; Tong X; Bateman TJ; Reddy VB; Fong TM; Hale JJ J Med Chem; 2010 May; 53(10):4028-37. PubMed ID: 20423086 [TBL] [Abstract][Full Text] [Related]
11. Dual inhibition of cannabinoid CB Udi S; Hinden L; Ahmad M; Drori A; Iyer MR; Cinar R; Herman-Edelstein M; Tam J Br J Pharmacol; 2020 Jan; 177(1):110-127. PubMed ID: 31454063 [TBL] [Abstract][Full Text] [Related]
12. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors. López Cara LC; Camacho ME; Carrión MD; Tapias V; Gallo MA; Escames G; Acuña-Castroviejo D; Espinosa A; Entrena A Eur J Med Chem; 2009 Jun; 44(6):2655-66. PubMed ID: 19117642 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold. Tu G; Xiong F; Huang H; Kuang B; Li S J Enzyme Inhib Med Chem; 2011 Apr; 26(2):222-30. PubMed ID: 20565336 [TBL] [Abstract][Full Text] [Related]